Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.56% | 14.36 | 14.2% | $227.60m | |
| SHPG | Shire PLC Sponsored ADR | 1.64% | 143.16 | 0.4% | $216.15m | |
| PRGO | Perrigo Co. Plc | 1.30% | 78.59 | 6.4% | $152.47m | |
| MNK | Mallinckrodt Plc | 2.77% | 37.13 | 17.7% | $118.19m | |
| UTHR | United Therapeutics Corporation | 1.13% | 131.28 | 13.9% | $88.16m | |
| JAZZ | Jazz Pharmaceuticals Plc | 2.89% | 146.74 | 2.2% | $81.28m | |
| ENDP | Endo International Plc | -1.64% | 8.38 | 8.9% | $71.09m | |
| HZNP | Horizon Pharma plc | -0.34% | 13.13 | 7.6% | $65.29m | |
| ALR | Alere Inc. | 0.22% | 49.55 | 2.7% | $64.57m | |
| PRXL | PAREXEL International Corporation | 0.07% | 87.73 | 7.9% | $63.41m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 2.31% | 107.09 | 22.1% | $62.54m | |
| MYOK | MyoKardia, Inc. | 1.27% | 43.80 | 3.0% | $53.28m | |
| NDRM | NeuroDerm Ltd. | -0.13% | 38.60 | 3.6% | $51.57m | |
| PTLA | Portola Pharmaceuticals, Inc. | 0.70% | 55.95 | 8.9% | $42.76m | |
| ICLR | ICON Plc | 2.46% | 107.89 | 4.2% | $41.33m |
Company Profile
VIVUS, Inc. operates as a biopharmaceutical company engages in the development and commercialization of novel therapeutic products. It offers the Qsymia for chronic weight management, as well as STENDRA and SPEDRA for erectile dysfunction. Its development also include Tacrolimus which is for the treatment of Pulmonary Arterial Hypertension. The company was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.